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Introduction
This article is meant to disseminate recent scientific progress on Gilles de la Tourette Syndrome (TS). This is the eighth
annual update for the Tics collection on F1000Research (https://f1000research.com/collections/tics). The authors eagerly
invite article suggestions for the 2022 highlights article at https://www.authorea.com/554771/.
Methods
We searched PubMed using the search strategy (“Tic Disorders”[MeSH] OR Tourette NOT Tourette [AU]) AND 2021
[PDAT] NOT 1950:2020[PDAT]. On 10 January 2022 this search returned 306 citations, available at this link.
Colleagues also recommended articles, and we attended selected medical conferences. We selected material for this
review subjectively, guided by our judgment of possible future impact on the field.
Results
Phenomenology and natural history
Definition
A very compelling data analysis and review argues for the conclusion that persistent (chronic) motor or vocal tic disorder
(PMVT) and Tourette Disorder (TS) are the same illness, or at least that “PMVT and TS occur along a clinical spectrum in
which TS is a more severe and PMVT a less severe manifestation of a continuous neurodevelopmental tic spectrum
disorder.”1
The European clinical guidelines for Tourette syndrome were updated (version 2.0) with regard to assessment of tic
disorders.2 As an introduction to these updated guidelines, it is well worth reading the summary statement3 and the
patients’ perspectives.4
Epidemiology
When it comes to sex differences, a review by Garris and Quigg described that although TS is more common in boys, tics
in girls tend to be more persistent.5 Also, comorbidity differed, with ADHD being more common in boys and mood and
anxiety disorders more common in girls. This topic was also explored by the European Multicentre Tics in Children
Studies (EMTICS) group who showed that males, in general, had more severe symptoms than females with the exception
of emotional problems. Since male symptoms seem more predominant at a younger age, their diagnosis might be
facilitated compared to females.6
As for the course of tics, another EMTICS study assessed clinical precursors of tics by comparing 61 high-risk children
who did develop tics in a seven-year follow-up period with 126 high-risk children who did not develop tics. Male sex,
severity of conduct problems, autism spectrum disorder (ASD), compulsions, and emotional problems were shown to be
precursors to tic occurrence.7
A study by Gromark and colleagues also tackled the topic of disease prognosis and course, but in a cohort of individuals
with Pediatric Acute-onset Neuropsychiatric Syndrome (PANS).8 Over a median of 3.3 years after the diagnosis, most
symptoms improved substantially and only 35% of children had a chronic, non-remitting course. These results suggest a
generally positive outcome for children diagnosed with PANS, and interestingly may not differ substantially from the
outcome in recent studies in non-PANS children, including the population of Provisional Tic Disorder.9,10
Another important report regarding treatment of tics comes from China.11 Demographic and prescription data
regarding tic disorder were extracted from the electronic medical records database of Beijing Children’s Hospital from
2018 to 2020. The authors paid special attention to treatment choices. All in all, 20,417 patients were included and 28.1%
(n=5028) of them were treatment-free. In contrast, 70% received anti-tic medication. In line with reports from other
countries, in children less than six years of age, clonidine was the most frequently employed medication (in particular,
clonidine adhesive patches, CAP). Another treatment option commonly used in this group was traditional Chinese
medication (TCM). As patients were older, the use of antipsychotics was growing. As for the number of medications
prescribed, 22% (n=3389) were treated with at least two compounds, with the most common combination being tiapride
and TCM (33.7%), followed by CAP and TCM (22.1%).
Regarding reports on particular types of tics, Kaczy
nska and Janik reported their experience with tonic (isometric) tics in
241 consecutive TS patients (including 153 children).12 Tensing of the abdomen was the most common localization,
followed by the neck and upper extremities. Tonic tics were common, occurred early in the course of the disease, and were
associated with greater number, severity and complexity of tics. The same authors covered the topic of blocking tics in the
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setting of a one-time registration study including 195 consecutive TS patients. Blocking tics were found frequently
(37.4%) and were early associated with more severe disease phenotype.13
The controversial topic of cognitive tic-like phenomena was studied by Janik and colleagues.14 They included
227 consecutive TS patients. Cognitive tic-like phenomena were defined as brief and sudden involuntary thoughts.
These phenomena occurred in 15% of patients and were correlated with older age, increased tic severity and anxiety
disorder.
David Mataix-Cols’s lab reported a national registry study of cervical spine injuries in TS. Risk of vascular and
nonvascular C-spine injuries were 38% to 57% higher compared to controls, without a significant difference by sex.
This epidemiological study confirms previous case reports and suggests that, although most TS patients do not injure their
spine, doctors should carefully monitor patients with severe disease or nuchal symptoms, and have a low threshold for
intervention, since these injuries can be serious and persistent.
An interesting case series described six patients whose driving capacity was impaired by their tics. This is a highly
relevant and rather frequent topic of discussion in TS clinics, and relies more on common sense than established
guidelines, as in epilepsy. On the same topic, a survey study with 228 adult participants with self-reported chronic tic
disorder (CTD) or TS showed that tics in most individuals did not influence driving.15 However, reported tic severity was
significantly higher among those without a driver’s license compared to those with a driver’s license, and tic severity was
indicated as cause of not having a driver’s license in 60.7%.
Comorbidity
Zinna and colleagues performed a retrospective, naturalistic study of all children with CTD and TS admitted to an
inpatient mental health unit during a 10-year period. 19.7% of the children needing inpatient treatment had comorbid
CTD/TS, especially with obsessive compulsive disorder (OCD), intellectual disability, and autism spectrum disorder.16
Moreover, presence of these co-existing disorders was associated with longer admissions. Interestingly, no association
with CTD/TS and attention deficit hyperactivity disorder (ADHD) was found. Park and colleagues performed a
retrospective review of medical records of 119 pediatric patients diagnosed with TS. The mean age at onset of tics
was 6.9 years and mean age at diagnosis was 8 years. 31.1% had at least one comorbid neuropsychiatric disorder.17 Tic
severity was associated with shorter time to diagnosis and greater functional impairment.
Vermilion and colleagues compared anxiety symptom profile in youth with tic disorders with a community control group
and a group of youths with clinically significant anxiety who were seeking anxiety treatment.18 A weak, but significant,
association between severity of tics and anxiety was found. Youths with tic disorders had similar anxiety severity as
youths with clinically significant anxiety, and significantly higher anxiety severity than healthy controls. Separation
anxiety severity in youths with tic disorders was significantly higher than in the group with anxiety.
Another Swedish registry study of over 10 million people found a 6.7-fold increased prevalence of insomnia in the 5,877
who had a recorded diagnosis of TS/CTD, after adjusting for demographics and somatic illness.19 Excluding people with
ADHD, ASD, or a sibling with TS/CTD reduced the odds ratio somewhat, suggesting that part of the risk is attributable to
familial factors or these two comorbid diagnoses. Medication for ADHD also increased the likelihood of insomnia. These
results suggest that assessment for sleep quality is important in managing TS. The association could be partly explained
by ADHD, ADHD medication, familial factors, and neurodevelopmental comorbidities. This was confirmed by the
findings in the meta-analysis by Keenan and colleagues, which included polysomnography studies in three groups of
patients: CTD-only, ADHD-only, and CTD+ADHD. The CTD+ADHD group had most sleep difficulties, but both in
CTD-only and CTD+ADHD group lower sleep efficiency and higher sleep onset latency were seen.20
The etiology of anger outbursts and aggressive symptoms in patients with TS may be multifactorial and influenced by
severity of illness and psychosocial factors.21 In relation to this topic, it is also worth mentioning a small case series
published by Kurvits and colleagues that explored the topic of allo-aggression and presented helpful tips to distinguish
between allo-aggressive behaviors and tics.22 The authors present cases of three patients with variety of complex
repetitive behaviors and allo-aggression (e.g., sudden kicking, hitting, slapping and biting others, or pushing someone off
a bike) which were mistaken for tics. An exhaustive clinical examination revealed the presence of red flag psychiatric
symptomatology atypical for TS, such as blackouts or feeling of being possessed by different personalities.
A very interesting study by Vicario and colleagues23 explored the topic of moral reasoning (MR) in TS. The hypothesis
about altered MR in TS is based on altered social cognition and reduced cognitive empathy that has been found in
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TS. Comparing the results of variety of tests assessing MR between 21 TS patients and 21 healthy controls, the authors
documented a greater tolerance of unethical behaviors in TS adolescents.
As for other, non-psychiatric comorbidities, in a cohort of 201 patients with TS, 33.3% turned out to have comorbid nontic movement disorders, particularly piano-playing movements (11%) and stereotypies (8%).24 The most common
etiology was drug-induced movements (6.0%) but in most cases no etiology was found and no association with severity of
tics was found. The presence of connective tissue-altered conditions, like joint hypermobility, was shown to be associated
with tic disorders.25
Premonitory urge and tic suppression
Several studies have explored the topic of premonitory urge (PU) in TS. Ramsey and colleagues26 investigated the nature
of relationship between PU and disease severity in TS using structural equation modeling. This analysis revealed that
higher levels of urge intolerance predicted greater levels of tic-related disability. Moreover, the association between urge
intolerance and tic-related disability was more pronounced in adolescents with internalizing symptoms. Another study,
by He and colleagues,27 used magnetic resonance spectroscopy to examine the pattern of alterations in γ-aminobutyric
acid (GABA) and glutamate neurotransmission in the following regions of the brain: the right primary sensorimotor
cortex (SM1), supplementary motor area (SMA), and insular cortex. Interestingly, neither GABA+ nor glutamine levels
were associated with tic diagnosis or severity. However, in children with TS, lower levels of SMA GABA+ were
associated with more severe and more frequent premonitory urges. The authors concluded that GABAergic neurotransmission in the SMA area is involved in the development of PU. Schubert and colleagues28 explored inter-individual
differences in PU and urge-tic associations in 21 adult patients with TS. They demonstrated that, as expected, at the group
level there was a positive association between PU and tic frequency and intensity. In addition, they demonstrated interindividual differences in associations between urges and tics. The majority of participants (57-66%, depending on the
measure that was used) demonstrated positive associations between tic severity and PU, but this was not the case for all
patients and in two cases there was a negative association with tic occurrence and PU.
As for studies focused on tic suppression, Morand-Beaulieu and colleagues29 investigated brain correlates of tic
suppression. They applied high-density electroencephalography at rest and during tic suppression. Graph theoretical
analyses showed a distinctive global network topology during tic suppression in comparison to rest. The authors
complemented their analysis with network-based statistics and found a subnetwork of increased connectivity during
tic suppression. The main regions of the brain involved in this network were right superior frontal gyrus and the left
precuneus. Interestingly, there was a condition-by-age interaction, suggesting that with age brain circuits responsible for
tic inhibition mature.
Other
Disease-related quality of life (QOL) in adults with TS at a subspecialty neurology movement disorders center did
significantly correlate with current tic severity.30 However, QOL was explained primarily by current non-tic symptom
severity (in decreasing order of correlation strength: anxiety, ADHD, and OCD, followed by the Yale Global Tic Severity
Scale [YGTSS] total tic score [TTS]). In a hierarchical regression analysis, the association of TTS with QOL was
statistically significant only after removing the other variables.
Adults with TS (n=53, compared to 53 tic-free controls) had higher levels of food sensitivity and avoidance, and food
neophobia was predicted by greater sensitivity to taste (gustatory hypersensitivity) in a study by Smith and colleagues.31
Etiology
Genetics
A genome-wide pathway analysis conducted by the TS/OCD working group of the Psychiatric Genomics Consortium
used 1,285 cases with TS and 4,964 ancestry-matched controls. The study identified three gene sets as differing in TS:
(i) ligand-gated ion channel signaling, (ii) lymphocytic (driven by variants in FLT3), and (iii) cell adhesion and transsynaptic signaling sets.32 These gene sets are in line with and reinforce previous hypotheses regarding the potential roles
of neuroinflammation, GABA, and cell adhesion in the pathophysiology of TS.
A cross-disorder genome-wide association study (GWAS) on 93,294 individuals revealed genes that contribute shared
genetic risk for TS in combination with ADHD, ASD, and OCD.33 Regarding the TS-ADHD-ASD association, tissue
specific analysis implicated the hypothalamus-pituitary-adrenal gland axis, in accordance with previous clinical studies
implicating this system in multiple childhood-onset psychiatric traits, including TS and ADHD.
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In a large (n=122) and densely-affected pedigree of individuals with TS, 66 DNA samples were available and analyzed
using different methods.34 Overall, this family had a high load of common risk alleles for TS, suggesting that multiple
common variants contribute more to risk than a few variants of strong effect.
Jones and collegues35 prospectively recruited 200 sequentially referred children with tic disorders/OCD, 100 autoimmune
neurological controls, and 100 age-matched healthy controls. Using a structured interview, the maternal and family
history of autoimmune diseases and other pro-inflammatory states was captured. Maternal blood and published Tourette
brain transcriptomes were analyzed for overlapping enriched pathways. Overall, this fascinating study suggested that
innate immune signaling may link maternal inflammation and childhood tics/OCD, and that targeting inflammation
may represent a plausible therapeutic target in neurodevelopmental disorders, including TS. This line of argument was
developed and expanded in two reviews on this topic by the same group.36,37
In an analysis of genome-wide DNA methylation patterns in whole blood samples from 16 monozygotic twin pairs (eight
discordant and six concordant for TS, plus two asymptomatic pairs), no site reached statistical significance, but a strong
association was suggested with genes belonging to the mTOR pathway, previously implicated in a variety of neuropsychiatric disorders.38
Environmental risk factors
The EMTICS study published its results testing the pediatric autoimmune neuropsychiatric disorders associated with
streptococcal infection (PANDAS) hypothesis.39 This study followed 715 children with TS/CTD for an average of
16 months. Tic severity was measured thrice annually, and infection with group A beta-hemolytic streptococcus (GAS)
was monitored carefully using pharyngeal swabs and serologic testing. The study identified 405 tic exacerbations in
308 participants, but these exacerbations did not correspond temporally to GAS exposure. The authors conclude that their
“study does not support GAS exposures as contributing factors for tic exacerbations in children with CTD. Specific workup or active management of GAS infections is unlikely to help modifying the course of tics in CTD and is therefore not
recommended.”39 These results and conclusion support those of previous studies.40
Ayubi and colleagues reviewed data from previously published epidemiological studies and concluded that maternal
smoking during pregnancy raised the risk of TS in their children by 35%.41
This year brought widespread attention to social contagion as a possible cause of sudden-onset tic-like symptoms in
adolescents. Such a phenomenon had been described previously, for instance ten years ago in a group of high school
students in the Rochester, New York, area,42,43 but in 2020, Müller-Vahl and German colleagues reported a rush of cases
among patients who did not know each other in person but had watched videos from the same social media personality
and showed his same symptoms.44 A report from London45 reported a similar phenomenon and was picked up by
numerous media outlets (a Google search on 13 November 2021 for “functional tic-like behaviors, TikTok, social media”
returned about 100 relevant results). Zea Vera and colleagues carefully examined popular ‘Tourette’ TikTok videos with
unusual symptoms and described a number of features of these videos that are highly unusual for TS.46 These features
include aggression (in 19% of these videos), self-injurious behaviors (28%), coprophenomena (over half), long phrases
(more than three words, 46%), throwing objects (22%), and very strong influence by the environment (over half). Senior
clinicians viewing these videos rated them on a Likert scale of one (“All the tics are typical of TS”) to five (“None of the
tics are typical of TS”). The median rating was five (interquartile range 4-5), meaning that almost none of these patients’
presentations even slightly resembled TS to these clinicians. A group from Lübeck and Dresden directly compared
demographic and clinical variables of 13 cases starting dramatically after social media exposure to 13 TS patients similar
in age and sex.47 A number of features were seen only in the post-social-media patients (i.e., 100% specific), including
abrupt symptom onset, first symptom being complex, primarily slow and tonic movements, mostly trunk or extremities, a
rapidly varying repertoire of symptoms, symptom deterioration in the presence of others, lack of spontaneous symptom
fluctuations over the course of weeks to months, a symptom involving goal-directed movement (e.g., directed at another
person), and dramatic context dependence. Symptoms continuing unabated throughout the examination was nearly as
specific (13 of 13, vs. 1 of 10 with TS). Copropraxia was present in over half, as was echolalia, and symptom onset was
significantly later (mean 15.3 years, vs. 5.2 years for TS). For all these reasons, most experts concluded that these
presentations comprised a functional movement disorder rather than a variant expression of TS.
One concern raised early in this FND epidemic was that If the very features clinicians used to define FND patients turned
out to be more common in their FND patients, one has not proved anything. Pringsheim et al authored one of the first
prospective studies that fully addresses that concern.48 They reported on a prospective cohort of 290 children with tic-like
phenomenology seen at Calgary. Twenty of these had rapid onset of clinically problematic tics. Crucially, these patients
were not defined by clinical judgment of FND, so the results cannot be circular. These 20 rapid-onset patients differed
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substantially from the remaining 270 children with a (typical) primary tic disorder. They were an average of 7.5 years
older at onset, 3.8 years older at the first visit to the center, had more severe tics (YGTSS total tic score 14.9 points higher
and impairment score 12.8 points higher, on average), and had more severe anxiety and depression scores (all of these
p < .0001). Several dichotomous features were significantly more common in the rapid-onset group, though specificity
for rapid-onset group membership was variable: 56% for ADHD, 84% for female sex, 81% for an anxiety disorder, and
96% for a depression diagnosis.The Tourette Association of America convened an international working group that
provided a summary and recommendations for assessment and care49; another helpful resource for patients is available at
NeuroSymptoms.org.50
Pathophysiology
Animal models
Benzodiazepines and ethanol are among the well-known positive allosteric modulators (PAMs) of GABA-A receptors.
A PAM highly selective for GABA-A receptors containing α6 subunits showed efficacy in the D1CT-7 transgenic mouse
model of tics.51 Dopamine antagonists showed similar effects but induced catalepsy, whereas this PAM did not. These
results suggest a strategy for future human studies, including for treatment of tic disorders; benzodiazepines are widely
prescribed for TS but there is a paucity of controlled data supporting their efficacy for tics.
Likely the most relevant and best established rodent models for tics have been developed by the group of Izhar Bar-Gad.
In this paper, they provide a comprehensive overview of their work so far.52
Electrophysiology
Electroencephalography
Several studies using electroencephalography (EEG) to elucidate the pathophysiology of tic disorders were published in
2021. An EEG study of lateral readiness potentials, a measure of activation and preparation of responses occurring in
motor cortical areas, showed that action integration per se was normal in patients with TS, suggesting that TS is not only a
movement disorder.53 EEG studies characterizing oscillatory activity and functional connectivity revealed that children
with tics exhibited abnormal activation and communication patterns within the frontal-parietal lobe network during
cognitive inhibition54 and that children with TS suppressed tics through a distributed brain circuit of cortical regions.29 In
an EEG study of TS patients and controls, movement-related EEG (i.e., mu- and beta-band oscillations) was examined
just before voluntary movements and tics were performed.55 Mu and beta oscillations were not observed before tics,
suggesting that a network of large brain regions (insular cortex, cingulate cortex, basal ganglia, cerebellum, etc.) is
involved in the development of tics. In the same study, beta-band desynchronization occurred when TS patients
initiated voluntary movements and, in contrast to healthy controls, no desynchronization of mu-band oscillations was
observed during the execution of voluntary movements, which was interpreted as a physiological inhibition impairment
in TS. Another study using EEG was conducted to calculate scale-free activity (1/f neural noise) based on the theory that
tics are behavioral surplus, or “motor noise”.56 Although task-related 1/f noise and high-frequency band aperiodic activity
were found to be increased in patients with TS during sensory-motor processing, there was no evidence that scale-free
and aperiodic activity was related to the process of tic development. The authors suggested that increased 1/f noise and
aperiodic activity are not directly related to tics, but more likely related to a new aspect of TS. Systematic review and
meta-analysis investigating the electrophysiological correlates of performance monitoring showed that error-related
negativity on EEG showed significantly increased amplitude in TS patients.57 However, this was based on only five
studies and there was a high degree of heterogeneity between studies.
Neuroimaging studies
In 2021, two voxel-based morphometry (VBM) meta-analyses were published.58,59 Their objectives were the same
(i.e., comparing TS patients to healthy controls), but they used different approaches and found different results. The first59
selected 10 studies and used a voxel-wise meta-analysis called seed-based d mapping. The second58 selected six studies
and used the more classical Activation Likelihood Estimation (ALE) method. They both reported increased gray matter
(GM) volume in the thalamus and the putamen and decreased GM in the postcentral gyrus. Surprisingly, their remaining
results differed and can therefore be considered more controversial: increased GM volume in the cerebellum (vermis III),
in limbic areas (striatum, insula, and hypothalamus) and in sensorimotor regions (pre- and post-central gyri); decreased
GM volume in frontal (inferior and medial parts and rolandic operculum), temporal (superior temporal gyrus) and parietal
cortices (supramarginal gyrus) as well as cingulate gyrus (anterior and posterior parts).
The anterior cingulate cortex (ACC) is largely suspected to play an important role in TS. A study using both VBM and
structural covariance network mapping focused on this region.60 This study found, first, decreased GM volume within the
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ACC and, second, increased structural covariance between the ACC and the motor parts of the cerebellum, the inferior
frontal cortex and the posterior cingulate cortex.
Interesting functional magnetic resonance imaging (fMRI) studies in TS were also published last year. One used
multivariate analysis with a support vector machine (SVM) to distinguish TD patients from healthy controls.61 This
classification algorithm reached a correct general accuracy of 67% to distinguish the two groups, especially on the basis of
resting-state fMRI data within the striatum, the fronto-parietal cortex, and the cerebellum. In addition, the authors
distinguished medicated and unmedicated patients with an accuracy of 69% based on the activity of the striatum, the
insular and cerebellar networks. These results and previous similar work62 show that resting state functional imaging
contains information relevant to distinguishing diagnosis and other clinical features in TS.
From a cognitive standpoint, the neural networks that underlie urge inhibition were assessed in TS patients with
obsessive-compulsive symptoms during a task involving blink suppression while viewing emotional (angry and neutral)
faces.63 The authors found that, compared to healthy controls, patients had higher activity in the superior temporal gyrus
and the middle cingulate cortex. In addition, by decomposing the task, they found that (1) tic severity was related to higher
activity during angry faces trials in comparison to neutral faces; (2) premonitory urge severity was related to higher
activity in the hippocampus, middle temporal gyrus, thalamus and caudate nucleus; and that (3) blink inhibition was
associated with decreased activity in both the thalamus and the insular cortex.
Another fMRI study focused on decisional impulsivity by using a delay-discounting task involving choosing between a
small immediate reward or a larger delayed reward.64 While they found no abnormal decisions in patients in comparison
to a group of healthy controls, the authors identified a subgroup of patients with higher impulsivity. This group was also
characterized by a higher burden of impulse-control disorders and a higher level of general impulsivity. In this group,
reward discounting was related to brain activity in a network comprising the orbito-frontal, cingulate, pre-supplementary
motor area, temporal and insular cortices, as well as ventral striatum and hippocampus. However, the most interesting
result was that a greater connectivity of pre-supplementary motor area with anterior insular cortex predicted both steeper
reward discounting and more severe tics. This suggests a relation between cognitive (decision-making) and motor (tics)
impulsivity in this subgroup of patients.
Pharmacological studies
Sturm and colleagues investigated inhibitory control abilities in 24 TS patients, 139 ADHD patients, 19 TD+ADHD
patients, and 59 typically developing controls aged nine to 14 years.65 Inhibitory control was measured using common
neurocognitive tasks [Attentional Network Task (ANT), Stop Signal Task (SST), Delis-Kaplan Stroop task, and
Go-Nogo task]. Surprisingly, their results did not confirm the inhibitory control deficit that had previously been found
in TS or TS+ADHD patients (reviewed by Morand-Beaulieu et al.66). But the originality of this paper was to evaluate
how inhibitory control deficit, tic severity (YGTSS), ADHD symptoms severity (by the Strengths and Weaknesses of
Attention-Deficit/Hyperactivity symptoms and Normal behaviors scale, SWAN), and subjective tic suppressibility
(item 10 on the Premonitory Urge for Tics scale, PUTS), contribute to objective tic suppressibility (tic suppression
paradigm67). The authors found that the only predictor of performance in the tic suppression paradigm was subjective tic
suppressibility, and that inhibitory control deficit, tics, and ADHD severity had no effect. As objective tic suppression is
known to be a potential mechanism of behavioral treatment response for TS patients, these findings have interesting
clinical implications.
Tic assessment
An important study by Haas and colleagues evaluated the psychometric properties of the gold standard for tic assessment,
namely the Yale Global Tic Severity Scale (YGTSS). The authors used a subsample of the EMTICS including
706 children and adolescents with a chronic tic disorder, and investigated convergent, discriminant, and factorial validity,
as well as internal consistency, of the YGTSS. The YGTSS demonstrated acceptable psychometric quality. Nevertheless,
they also showed that there is a need for further improvement of some items, for example, the global severity (total) score,
indicating that separate use of the total tic score and the impairment rating is more beneficial.68
Psychometric properties of the Chinese version of the YGTSS were explored by Wen and colleagues.69 The authors
included 367 children and adolescents with tic disorders and tested both reliability and validity. Overall, the Chinese
version of YGTSS showed good psychometric properties. Similarly, Li and colleagues70 tested the psychometric
properties of another gold standard scale used in tic research, the Premonitory Urge for Tics scale (PUTS), in the
Chinese population. No differences regarding PU manifestation were found in diverse age groups. The exploratory factor
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analysis of PUTS demonstrated the emergence of four primary factors. Finally, reliability and validity analyses indicated
that the Chinese version of PUTS had good psychometric properties.
Many studies have focused on the development of new assessment tools for tic assessment, especially using new
technologies. In one study by Eriguchi and colleagues, the authors tested a new method used to quantify the angular
movements of neck tics using a compact gyroscope. The authors also investigated the clinical course of neck tics during a
follow-up period of two years. Although the authors did not detect any changes in intensity and frequency of neck tics
during the follow-up period, the gyroscope proved to be a valuable solution to monitor severe, healthy, or even lifethreatening neck tics.71 Another approach using new technologies was proposed by Cernera and colleagues who tested a
sensor-based technology called ‘the human tic detector’ to detect and classify tics.72 The authors recorded both surface
electromyogram and acceleration data from 17 patients with TS when performing voluntary and involuntary movements
(tics) using the modified Rush Video Tic Rating Scale (mRVTRS). In addition, they evaluated spectral properties of
voluntary and tic movements with a sensor capturing the dominant tic and used a support vector machine (SVM) to detect
and classify movements. It was demonstrated that wearable sensors can be used to distinguish between tics and voluntary
movements and are comparable to expert consensus. Paulus and colleagues analyzed videos of 101 patients with TS and
109 healthy controls according to the Modified Rush Videotape Rating using a machine learning-based analysis. Severity
of motor tics was shown to be the best predictor of a diagnosis of TS. Interestingly, vocal tics did not predict TS diagnosis,
which might challenge the validity of the current diagnostic criteria for TS.
One important analytical avenue used both for data analysis as well as development of tic assessment algorithms
is artificial intelligence. This approach was used by Wu and colleagues, who attempted to find an automatic method
for detecting tics to assist in diagnosis and evaluation.73 Based on clinical data, the authors proposed a deep learning
algorithm using both unsupervised and supervised learning and learning features from videos for tic motion detection.
Taken together, the proposed models demonstrated satisfactory recognition between tics and non-tic movements, and the
authors concluded that this methodology could be potentially useful in clinical care.
Treatment
Psychological interventions
Treatment guidelines published by the American Academy of Neurology (AAN) in 201974 and the European Society for
the Study of Tourette Syndrome (ESSTS) in 202175 recommend behavior therapy (BT) as the first-line intervention
for TS/CTD. Out of several types of BT, recommendations are primarily for Habit Reversal Training (HRT) and its
extended package Comprehensive Behavioral Intervention for Tics (CBIT), and secondarily for Exposure and Response
Prevention (ERP).
Several research groups are currently investigating ways to make BT more accessible to healthcare seeking TS/CTD
individuals, including various remote formats. In a British randomized controlled trial (RCT) by Hollis and colleagues,76
referred to as the ORBIT study, 224 young TS/CTD individuals were randomized to therapist-supported, internetdelivered ERP (the previously piloted Swedish BIP TIC ERP program77) or a therapist-supported, internet-delivered
psychoeducation comparator. Participants in the ERP group improved on average 4.5 points (16%) on the primary
outcome (tic severity as measured by the YGTSS-TTSS) from baseline to post-treatment, compared to 1.6 points (6%) in
the comparator group, a significant interaction of group and time showing superiority for the BIP TIC ERP intervention.
The ORBIT study is a significant contribution to the field, being the largest study of BT for TS/CTD to date and the first
study to show ERP to be superior to an active control intervention. An ongoing similar Swedish RCT will further add to
the evaluation of the BIP TIC ERP program.78 Time will tell whether BIP TIC ERP will be implemented into regular
healthcare.
The internet-delivered format has also recently been evaluated among adults. In a German RCT by Haas and colleagues,79
161 adult TS/CTD individuals were randomized to unsupported internet-delivered CBIT (n=67), unsupported internetdelivered psychoeducation (n=70), or face-to-face CBIT (n=24). The primary comparison between the two internetdelivered interventions showed a trend towards superiority of internet-delivered CBIT in reducing tic severity
(as measured by the YGTSS-TTSS) at the primary endpoint (post-treatment). This trend later evolved to a statistically
significant superiority of internet-delivered CBIT at follow-ups three and six months post-treatment. Even though the tic
severity improvements were lower than in RCTs of face-to-face CBIT, and the study experienced relatively high dropout
rates, internet-delivered CBIT may be a cost-effective (i.e., no therapist support is required) and helpful treatment option
for some TS/CTD individuals.
A few smaller studies have also investigated remote treatment formats. Viefhaus and colleagues80 piloted a blended
approach, where online therapist support via videoconferencing was added to a regular face-to-face HRT intervention.
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The aim was two-fold: to provide therapist support for homework directly and to reduce the need for travel to the clinic.
The format was shown feasible in a case series of children and adolescents (N=5). Reese and colleagues81 conducted a
pilot study (N=8) of an online mindfulness-based intervention (self-help mixed with therapist-supported group sessions
via videoconferencing) for adults with TS/CTD. The authors concluded that the intervention was feasible and acceptable,
but that participant adherence to the mindfulness homework assignments was lower than expected. Individual improvements in YGTSS-TTSS were also modest. Further refinement and evaluation of this intervention is needed.
A traditional group format, without the online component, may also be an efficient way to save therapist resources and
promote the dissemination of BT. Zimmerman-Brenner and colleagues82 randomized 61 young TS/CTD individuals to
group CBIT or group psychoeducation. The study showed somewhat mixed findings, with no significant between-group
effect on the YGTSS-TTSS at the primary endpoint. Unexpectedly, tic severity increased in both groups between baseline
and post-treatment, to later decrease at three-month follow-up. The temporary increase in symptoms seems to have been
driven by an increase in vocal tic severity, potentially a side effect of the group format. Limitations included not including
a power calculation nor performing intention-to-treat analyses.
During 2021, a few variations and extensions of previous studies of face-to-face CBIT were also conducted. In a small
pilot study (N=6), Peterson and colleagues83 investigated the specific effect of relaxation training as part of the CBIT
package (alongside HRT and function-based interventions). The study concluded that relaxation training alone was not
effective in reducing tic severity; rather, it should be included in conjunction with other CBIT elements.
Espil and colleagues84 followed up young participants 11 years after receiving CBIT or supportive therapy and education
(comparator) in the Piacentini and colleagues RCT from 2010.85 This is the longest published prospective follow-up to
date of TS/CTD individuals having received BT. The results showed a significant tic severity decrease across the sample
during the follow-up period. Further, treatment responders to both interventions in the original study achieved at least
partial tic remission during the follow-up period (a YGTSS-TTSS score <14), of which treatment responders in the CBIT
group were more likely to achieve remission than treatment responders in the comparator. Despite limitations such as
confounding TS/CTD interventions during the follow-up period and data loss, the study indicated good durability of the
effects of BT.
Also based on previous RCTs of CBIT,86 Essoe and colleagues87 investigated the relation between homework
adherence and treatment outcomes. The results showed that greater overall homework adherence predicted tic severity
reductions and treatment response. Essoe and colleagues separately reviewed literature on the working mechanism of
BT for TS/CTD.88 This review showed that mechanisms appear to differ between youth and adults. Data primarily
supported associative learning (e.g., positive reinforcement) and cognitive control (e.g., active tic inhibition) as
mechanisms, while habituation may be a mechanism for adults only. Interpretation is made difficult by a mixture of
laboratory and clinical studies, overall small sample sizes, and different ways to measure phenomena such as premonitory
urge intensity.
Medication
The European clinical guidelines for Tourette syndrome were updated (version 2.0) with regard to pharmacological
treatments.89
A number of randomized controlled studies have investigated the potential efficacy of new (extended release) VMAT2
inhibitors for the treatment of tics. To date, the mother compound, tetrabenazine, has been used largely off label for tic
treatment in the absence of evidence derived from high quality clinical studies. Alas, both deutetrabenazine90,91 and
valbenazine failed to meet primary endpoints in their respective studies.92
An interesting case series described six children or adolescents with aggressive behaviors in whom lurasidone, a novel
antipsychotic, was added to either aripiprazole or risperidone; the addition of lurasidone appeared to diminish these
symptoms with good tolerability.93
Interest in cannabis (and, more generally, the cannabinoid system) in the treatment of tics is ongoing. Monoacylglycerol
lipase inhibition to increase levels of 2-arachidonoylglycerol (2-AG), an endocannabinoid, was tested in a 12-week,
multicenter, randomized, placebo-controlled, double-blind clinical trial using a compound called Lu AG06466 (formerly
known as ABX-1431). This was a phase two trial in adult patients with TS. There were no significant differences on the
YGTSS between groups, nor for other endpoints assessing tic severity, premonitory urges, quality of life, and common
psychiatric comorbidities. Further development of the compound for tics/TS was abandoned.94 In contrast, encouraging
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results were obtained by Bloch and colleagues for THX-110, a combination of Δ9-tetrahydracannabinol (Δ9-THC) and
palmitoylethanolamide (PEA) in a 12-week uncontrolled trial in 16 adults patients with TS.95 Tic symptoms improved
on average by more than 20% (=7-point decrease in the YGTSS score), and 12 of the 16 participants elected to continue to
the extension phase. However, tolerability was slightly tricky and, of course, these results now require validation in
randomized double-blind placebo-controlled trials.
Finally, another treatment target in TS might be the serotonergic system. Pimavanserin, a serotonin 2A receptor inverse
agonist and antagonist, was tested in an open label trial over eight weeks in 10 adult patients with TS. A small but
noteworthy decrease in tic severity (-12%) was noted on the YGTSS-TTS, as well as improvements on scales assessing
global clinical impression and quality of life. Here too, larger, placebo-controlled trials are warranted.96
Neurosurgery
Several important papers have been published in 2021, which provide interesting insights for clinical management of
these patients and also for the better understanding of the neural bases and brain targets involved in deep brain stimulation
(DBS) effects.
Two important guidelines papers were published this year, which may be useful to refine inclusion criteria for DBS in TS
patients. Szejko and colleagues published a revised version of the ESSTS guidelines on DBS based on data from the
literature and the International Tourette DBS registry and database. Important takeaways from these guidelines include:
i) the importance of excluding ‘tic-like’ functional movement disorders before considering DBS; ii) the fact that reduction
of tics should be the main objective of DBS aimed at tics, and thus the importance of ensuring that tics are the primary
source of impairment; iii) the inclusion of patients who are refractory to pharmacologic and behavioral therapies; iv) the
fact that DBS should be very cautiously considered in children and teenagers due to the frequent improvement of tics
in adulthood; and v) the importance of performing DBS following a specified protocol within the context of controlled
trials, cohort studies or registry databases.97 These recommendations are in line with the opinion paper by Martino and
colleagues, about the ‘five pillars’ for considering TS patients for DBS: i) high tic severity; ii) tic-related impact on quality
of life; iii) treatment refractoriness; iv) stability of comorbid psychiatric disorders for six months; and v) multidisciplinary
and particularly careful assessment of indications for patients under 18.98
Two RCTs have been published which add to the data on efficacy of DBS in TS. Baldermann and colleagues published a
trial involving eight patients with stimulation of the Cm-Voi nuclei of the thalamus with an interesting design of
combined naturalistic open label with brief randomized, sham-controlled assessments.99 They showed an improvement
of tics with stimulation ON compared to sham stimulation, and an improvement in quality of life. Another study by
Müller-Vahl and colleagues provided mixed findings. Their study involved 10 patients randomized to either sham, GPi,
or thalamic stimulation. They found an improvement of tics with GPi stimulation and a superiority to GPi over thalamic
and sham stimulation, with no overall improvement in quality of life, and with an important variability across patients.
Importantly, four patients out of 10 had to be re-operated due to cable dysfunctions, and six years after surgery, five out of
10 patients had their stimulation turned off due to infections, technical problems, or lack of efficacy.100 In an interesting
clinical paper, MacLean et al., report the complete resolution of GTS symptoms after the placement of stereo-EEG
electrodes in the GPi and nucleus accumbens and suggest that stimulation at multiple patient-specific targets could
provide effective control of GTS symptoms.This approach warrants further study.101
Regarding the neural bases of DBS in GTS and the question of optimal stimulation target, several novel findings
are worthy of attention. In a retrospective study involving 35 patients, Johnson and colleagues highlighted the important
variability in pathway activation across patients and stimulation settings.102 They showed a correlation between tic
improvement and predicted activation of the associative pallido-subthalamic pathway, the ansa lenticularis, and the
internal capsule tracts projecting to the prefrontal cortex. Anterior GPi stimulation may act via associative and limbic
pathways modulation, whereas posterior GPi stimulation may have an effect on sensorimotor networks. Interestingly,
Aminzade and colleagues reported the case of a patient with improvement of OCD, without improvement of tics, after
anteromedial GPi stimulation.103
A systematic review on clinical responses to several DBS targets in patients with TS showed fiber connectivity to be
important in target selection because the effects of DBS on tics seem to occur through different networks at different
stimulation sites.104 Finally, an interesting case report described a patient with major depressive disorder who developed
voltage-dependent coprolalia and tic-like movements along with changes in emotion, mood, and memory after DBS of
bilateral ventral internal capsule and ventral striatum.105
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Transcranial magnetic stimulation
Focusing on the benefits of noninvasive brain stimulation as a potential treatment for TS, methodological (e.g.,
transcranial magnetic stimulation (TMS), transcranial direct current stimulation) and theoretical issues,106 and TMS
as a potential marker for TS107 were discussed. Dual-site TMS and diffusion tensor imaging showed reduced prefrontal
(pre-SMA) inhibition in children with TS/CTD compared to controls and the decreased inhibition correlated with
impairment of tic suppressibility.108 In addition, increased fractional anisotropy was observed in several white matter
pathways in patients with TS/CTD, supporting a plausible pathophysiological mechanism associated with tic persistence.
Dyke et al., present an exhaustive review of non-invasive brain stimulation in the treatment of TS.106 One original study
on low-frequency repetitive transcranial stimulation (rTMS) that stands out uses the bilateral parietal cortex as the target
zone for the treatment of tics. The results, in 30 adult patients with TS, were very encouraging on all measures (YGTSS,
MRVBTS and PUTS scores). Importantly, the beneficial effects lasted for up to a month after the last rTMS session.109
This approach warrants replication and extension in larger cohorts. In children (n=10), bilateral rTMS of the supplementary motor area was well tolerated and decreased tic severity post-treatment.110 However, this was an open label trial
and requires confirmation in a blinded setting, and preferably over longer time periods.
Other treatments
The Movement Disorders Society Tourette Syndrome Study Group performed a Delphi survey amongst 36 international
experts in 14 countries to better define the concept of treatment failure in persistent tic disorders, both with regard to
pharmacological and behavioral therapy.111 An operational definition was proposed and its feasibility now needs to be
assessed in clinical decision making, for instance in choosing candidates for DBS. The Movement Disorders Society
Tourette Syndrome Study Group also published a survey on clinical practice patterns in tic disorders and concluded that
tic disorders remain understudied beyond a scope of dedicated experts, and that diagnosis and treatment still requires
improvement across the globe.112
Tics, family, and society
Several tic experts argued that, although TS is not a rare disease according to international classifications, it remains
understudied and should therefore qualify for public health regulations that direct funding to treatment research for
orphan or neglected diseases.113 This is also reflected by an excellent review highlighting the scarcity of specialized TS
clinics and dedicated experts.114 This international group investigated health service delivery and care practices by
clinicians in different geographical settings (Canada, US, Europe, and the United Kingdom). The results suggested that
there is a scarcity of specialized TS clinical care in all investigated regions. Similarly, a study from the Tourette OCD
Alberta Network reported on pitfalls and solutions for development of systemic care networks for tic detection.115 In this
mixed-methods study, 10 parents were interviewed in person and 140 parents responded to a survey. Qualitative data
showed there was often an absence of a clear pathway to access healthcare for people with TS and OCD. Importantly,
several solutions to tackle this problem were identified, such as: preparation of school-based training webinars,
educational outreach in schools, and peer support.

Figure 1. Publications on Tourette syndrome indexed annually by the (U.S.) National Library of Medicine. Image
created by authors.
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Quality of life
Lee and colleagues116 explored the role of self-esteem in mediating the relationship between psychosocial stress and
social adjustment among adolescents with TS. Self-esteem of adolescents with TS fully mediated the relationship
between psychosocial stress and social adjustment, while comorbidities moderated the relationship between self-esteem
and social adjustment.
Solis-Garcia et al.,117 studied quality of life and psychiatric comorbidities in pediatric patients with TS. In accordance
with previous reports, higher severity of tics and ADHD were associated with poorer quality of life.
Conclusions
The year 2021 saw publication of important work on a variety of fronts. Larger and collaborative studies produced
ever more frequent, important contributions. On the other hand, the flexibility of the TS clinical and research community
was demonstrated by its response to the explosion of rapid-onset Tourette-like cases, beginning with rapid publication
of case series but progressing quickly over the past one to two years to include international collaborations, controlled
investigations, and prospective follow-up studies. Of perhaps greatest interest to our patients, new and actionable
information appeared regarding numerous approaches to treatment of TS. These included the full range from psychological interventions to pharmaceuticals to non-invasive and invasive brain stimulation, and several clinical trials
examined approaches that increased the availability of care at lower cost and to patients for whom frequent visits to a
specialty center are difficult or impossible.
Keeping up with the relevant literature on TS has become increasingly difficult. Over the eight years since we began this
yearly review, PubMed has indexed almost 2,000 new publications dealing with Tourette syndrome and other tic
disorders, with a record 300 publications in 2021 (see Figure 1). Despite the length of this review, the authors suspect that
we have omitted some important work or may have overstated the relevance of a publication mentioned above. To
improve these reviews, we warmly invite readers both to comment on this article after publication and to nominate
important articles from 2022 (including their own best work) by commenting on the draft for next year’s highlights article.

References
1.

Claudio-Campos K, Stevens D, Koo SW, et al.: Is Persistent Motor or
Vocal Tic Disorder a Milder Form of Tourette Syndrome?
Mov. Disord. 2021; 36: 1899–1910.
PubMed Abstract|Publisher Full Text

2.

Szejko N, Robinson S, Hartmann A, et al.: European clinical
guidelines for Tourette syndrome and other tic disordersversion 2.0. Part I: assessment. Eur. Child Adolesc. Psychiatry. 2022;
31: 383–402.
Publisher Full Text
Müller-Vahl KR, Szejko N, Verdellen C, et al.: European clinical
guidelines for Tourette syndrome and other tic disorders:
summary statement. Eur. Child Adolesc. Psychiatry. 2022; 31:
377–382.
Publisher Full Text

3.

4.

Anderson SM: European clinical guidelines for Tourette
Syndrome and other tic disorders: patients’ perspectives on
research and treatment. Eur. Child Adolesc. Psychiatry. 2022; 31:
463–469.
Publisher Full Text

5.

Garris J, Quigg M: The female Tourette patient: Sex differences in
Tourette Disorder. Neurosci. Biobehav. Rev. 2021; 129: 261–268.
Publisher Full Text

6.

Garcia-Delgar B, Servera M, Coffey BJ, et al. : Tic disorders in
children and adolescents: does the clinical presentation differ
in males and females? A report by the EMTICS group. Eur. Child
Adolesc. Psychiatry. 2021.
PubMed Abstract|Publisher Full Text

7.

Openneer TJC, Huyser C, Martino D, et al.: Clinical precursors of
tics: an EMTICS study. J. Child Psychol. Psychiatry. 2022; 63: 305–314.
PubMed Abstract|Publisher Full Text

8.

Gromark C, Hesselmark E, Djupedal IG, et al.: A Two-to-Five Year
Follow-Up of a Pediatric Acute-Onset Neuropsychiatric
Syndrome Cohort. Child Psychiatry Hum. Dev. 2022; 53: 354–364.
Publisher Full Text

9.

Black KJ, Kim S, Schlaggar BL, et al. : The New Tics study: A Novel
Approach to Pathophysiology and Cause of Tic Disorders.
J. Psychiatr. Brain Sci. 2020; 5.

10.

Kim S, Greene DJ, Bihun EC, et al.: Provisional Tic Disorder is not so
transient. Sci. Rep. 2019; 9: 3951.
PubMed Abstract|Publisher Full Text

11.

Wang N, Qin DD, Xie YH, et al.: Traditional Chinese
Medicine Strategy for Patients with Tourette Syndrome
Based on Clinical Efficacy and Safety: A Meta-Analysis of
47 Randomized Controlled Trials. Biomed. Res. Int. 2021; 2021:
6630598.

12.
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Thank you for the opportunity to review this comprehensive review of the 2021 literature covering
Tourette syndrome (TS) and related disorders. The authors did a wonderful job presenting a
thorough, detailed, yet succinct summary of an enormous number of new, important articles in
the field. I appreciated that they showed the growth of research in TS over the last forty years, and
are open to creative ways to make sure they have access to the likely even larger 2022 literature
base. They covered a range of topics, broken down in effective sections, including Phenomenology
and Natural History, Pathophysiology, Electrophysiology, Treatment, each with its own
appropriate subsections. The authors presented the brief summaries of the literature clearly, and
without bias.
I only have a few comments/recommended adjustments that I would suggest the authors
consider following up on.
Under Epidemiology, starting "The controversial topic of cognitive..." - it would help if the
authors add a sentence clarifying why that phenomena is not considered OCD/intrusive
thoughts.
○

○

○

○

Under Comorbidity, starting "A very interesting study..." - I would recommend either
eliminating that or expanding on it, as the findings are quite provocative, and given the
sample size was so small, I worry about it being given more attention than warranted
without further studies to validate (and/or without commenting on co-occurring conditions
that may also influence moral reasoning).
Under Premonitory Urge and Tic Suppression, starting "Another study, by He..." - I would
make that a new paragraph
Under Environmental Risk Factors, starting "This year brought," I would recommend
condensing the paragraph to make it more in line with the other summaries, particularly
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related to citations 46 and 47. Given that they were small studies, particularly 47, I would
recommend not listing all the findings/differences (particularly as I wonder about multiple
comparisons in that study..). Related, I would soften the sentence saying "meaning that
almost none of these patients' presentations even slightly resembled TS to these clinicians"
as it sounds more subjective/intense than the rest of the paper. And I would soften the
language in the paragraph starting "One concern..." as again, it read as more
subjective/opinion-driven than the rest of the manuscript.
○

○

○

○

○

In the paragraph starting, "Sturm and colleagues..." I believe the heading above it is
incorrect.
Under Tic Assessment, starting "Many studies have focused..." it would help to clarify the last
sentence starting, "Interesting vocal tics..." Without more context, it is difficult to understand
why vocal tics not predicting TS diagnosis might challenge the validity of diagnostic TS
criteria vs challenge the validity of the SVM (support vector machine)?
Under Treatment Psychological interventions, starting "Several research groups..." - it would
help to spell out what the acronym BIP means
In the figure depicting the increase in TS related literature over time, it looks like the legend
is flipped
In Conclusions, I wonder if the authors mean to say "Additionally" rather than "On the other
hand."
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We thank Dr Greenberg for her positive evaluation of our manuscript and her helpful
comments. We have incorporated nearly all comments except the passages on FND which
we did shorten only marginally. Because many readers will not be familiar with the clinical
presentation of these patients, a bit more detail seemed appropriate to us even if the case
numbers were small. However, we agree that in the absence of larger studies and harder
data (coming up in 2022, hopefully!), much is opinion-driven at this stage. Also, we do not
know what the BIP in BIP TIC stands for, it is an abbreviation that has been used by the
Karolinska group from the beginning and might actually be Swedish. Finally, we believe the
figure legend to be adequate.
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The authors provide a good overview of the current literature. This annual summary of the current
scientific literature is an important milestone for people active in Tourette's research and
treatment to keep themselves informed.
The selection of literature is presented clearly and understandably. Perhaps the categories into
which the selected literature is placed could also be presented in an overview at the beginning.
Such a list would make reading even more straightforward. The authors mention that they have
also integrated congress contributions. A list of the selected congresses would be desirable.
There is an interesting graph at the end of the review about the increasing number of annual
publications in the field. Probably the number of publications is still too small; if not, a map from
which countries how many publications come, and from which countries how many publications
are taken into account (e.g., by the size and color of dots on a map) would be an interesting, but
not necessary information for the publication.
The present manuscript is a very successful work that merits indexing in this form.
Is the topic of the review discussed comprehensively in the context of the current
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We thank Dr Alvarez-Fischer for his kind comments on our manuscript. The figure was a
labor of love by Dr Black and adding geographic information is beyond what we can offer, at
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